Immediate Impact
60 standout
Citing Papers
Integration of 168,000 samples reveals global patterns of the human gut microbiome
2025 Standout
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
2025 Standout
Works of Petar Šćepanović being referenced
A randomized, double‐blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis
2023
A comprehensive assessment of demographic, environmental, and host genetic associations with gut microbiome diversity in healthy individuals
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Petar Šćepanović | 139 | 46 | 25 | 60 | 56 | 8 | 249 | |
| Flavia Hodel | 123 | 48 | 51 | 51 | 69 | 12 | 278 | |
| Vesla Kullaya | 91 | 42 | 28 | 62 | 57 | 15 | 241 | |
| Mangge Zou | 134 | 26 | 35 | 130 | 39 | 11 | 290 | |
| Georgia Lattanzi | 140 | 23 | 30 | 48 | 91 | 11 | 274 | |
| Megumi Murata | 144 | 36 | 29 | 89 | 72 | 14 | 274 | |
| Sureka Gattu | 161 | 22 | 27 | 80 | 33 | 5 | 284 | |
| Bruno Charbit | 88 | 51 | 21 | 68 | 67 | 12 | 233 | |
| Kevin Y. Cunningham | 199 | 34 | 20 | 27 | 43 | 8 | 298 | |
| Rebecca Rogier | 167 | 47 | 58 | 73 | 60 | 9 | 286 | |
| Stefanie Ascher | 125 | 34 | 8 | 44 | 29 | 8 | 222 |
All Works
Login with ORCID to disown or claim papers
Loading papers...